Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 1 Thirty-day mortality model for patients without absolute contraindications to thrombolytic therapy, stratified by clinical and hospital characteristics. The odds ratio and 95% confidence intervals for thrombolysis (solid line) and primary angioplasty (dashed line) are compared with no reperfusion strategy at 30 days. The results are stratified by clinical and hospital characteristics and also demonstrated for the combined study sample. Points to the left of 1.00 indicate a benefit of the therapy whereas point estimates to the right of 1.00 indicate a detrimental effect.
